China First Stop On FDA’s Itinerary For Establishing Overseas Staff Posts
This article was originally published in The Tan Sheet
Executive Summary
FDA is considering posting staff overseas to perform inspections and foster relationships with foreign government counterparts and industry
You may also be interested in...
FDA Strengthens Inspections Of Chinese Drug Firms In Heparin Aftermath
BEIJING - As FDA leaders select inspectors to deploy across three offices being set up in China, the agency is also preparing to ramp up the number of inspections and the level of scrutiny of Chinese drug manufacturers that export to the U.S
FDA Strengthens Inspections Of Chinese Drug Firms In Heparin Aftermath
BEIJING - As FDA leaders select inspectors to deploy across three offices being set up in China, the agency is also preparing to ramp up the number of inspections and the level of scrutiny of Chinese drug manufacturers that export to the U.S
FDA Strengthens Inspections Of Chinese Drug Firms In Heparin Aftermath
BEIJING - As FDA leaders select inspectors to deploy across three offices being set up in China, the agency is also preparing to ramp up the number of inspections and the level of scrutiny of Chinese drug manufacturers that export to the U.S